NYSE:GMREGlobal Medical REIT Stock Price, Forecast & News

Global Medical REIT's stock was trading at $12.41 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, GMRE stock has decreased by 13.6% and is now trading at $10.72. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Global Medical REIT.

Global Medical REIT is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Global Medical REIT.

Global Medical REIT Inc (NYSE:GMRE) announced its quarterly earnings data on Wednesday, May, 6th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.20 by $0.17. The business earned $21.65 million during the quarter, compared to the consensus estimate of $21.04 million. Global Medical REIT had a return on equity of 2.58% and a net margin of 11.13%. View Global Medical REIT's earnings history.

Global Medical REIT announced a quarterly dividend on Tuesday, March 3rd. Stockholders of record on Wednesday, March 25th will be given a dividend of $0.20 per share on Thursday, April 9th. This represents a $0.80 annualized dividend and a dividend yield of 7.46%. The ex-dividend date of this dividend is Tuesday, March 24th. View Global Medical REIT's dividend history.

5 analysts have issued twelve-month target prices for Global Medical REIT's shares. Their forecasts range from $12.00 to $17.00. On average, they anticipate Global Medical REIT's share price to reach $15.10 in the next twelve months. This suggests a possible upside of 40.9% from the stock's current price. View analysts' price targets for Global Medical REIT.

Media stories about GMRE stock have trended very negative this week, according to InfoTrie. The research group identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Global Medical REIT earned a daily sentiment score of -3.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 3.0 out of 10, indicating that recent news coverage is unlikely to have an impact on the company's share price in the next few days. View the latest news aboutGlobal Medical REIT.

Some companies that are related to Global Medical REIT include Ryman Hospitality Properties (RHP), Easterly Government Properties (DEA), Caretrust REIT (CTRE), Pebblebrook Hotel Trust (PEB), Washington Real Estate Investment Trust (WRE), Paramount Group (PGRE), RLJ Lodging Trust (RLJ), Brandywine Realty Trust (BDN), CHIMERA INVT CO/SH NEW (CIM), American Assets Trust (AAT), Uniti Group (UNIT), Columbia Property Trust (CXP), Four Corners Property Trust (FCPT), Corecivic (CXW) and The GEO Group (GEO). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include Principal Financial Group (PFG), Insys Therapeutics (INSY), General Electric (GE), Square (SQ), Big Lots (BIG), New Residential Investment (NRZ), Ready Capital (RC), AGNC Investment (AGNC), AT&T (T) and Energy Transfer LP Unit (ET).

(GMRE) raised $130 million in an IPO on Wednesday, June 29th 2016. The company issued 13,000,000 shares at $10.00 per share. Wunderlich and Oppenheimer served as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."

Global Medical REIT's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (6.72%), State Street Corp (2.09%), Wells Fargo & Company MN (1.91%), Geode Capital Management LLC (1.29%), Invesco Ltd. (1.18%) and JPMorgan Chase & Co. (0.89%). Company insiders that own Global Medical REIT stock include Henry Cole, Ronald Marston, Roscoe M Moore Jr and Zh Usa, Llc. View institutional ownership trends for Global Medical REIT.

GMRE stock was sold by a variety of institutional investors in the last quarter, including Invesco Ltd., Two Sigma Investments LP, Foundry Partners LLC, Nuveen Asset Management LLC, ClariVest Asset Management LLC, UBS Group AG, Chicago Equity Partners LLC, and WINTON GROUP Ltd. View insider buying and selling activity for Global Medical REIT.

GMRE stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., State Street Corp, Crown Advisors Management Inc., JPMorgan Chase & Co., Virtus ETF Advisers LLC, Geode Capital Management LLC, Wells Fargo & Company MN, and Wedge Capital Management L L P NC. Company insiders that have bought Global Medical REIT stock in the last two years include Henry Cole, Ronald Marston, and Zh Usa, Llc. View insider buying and selling activity for Global Medical REIT.

Shares of GMRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of GMRE stock can currently be purchased for approximately $10.72.

Global Medical REIT has a market capitalization of $482.51 million and generates $70.73 million in revenue each year. The company earns $9.23 million in net income (profit) each year or $0.75 on an earnings per share basis.

The official website for Global Medical REIT is www.globalmedicalreit.com.

Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The company can be reached via phone at 202-524-6851.